NovaBay Pharmaceuticals, Inc. Accounts Payable

Accounts Payable of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Accounts Payable growth rates and interactive chart. Accounts payable (AP) represents a company's obligation to pay off a short-term debt to its creditors or suppliers. Accounts payable are amounts due to vendors or suppliers for goods or services received that have not yet been paid for. The sum of all outstanding amounts owed to vendors is shown as the accounts payable balance on the company's balance sheet. The increase or decrease in total AP from the prior period appears on the cash flow statement.


Highlights and Quick Summary

  • Accounts Payable for the quarter ending September 30, 2022 was $1.1 Million (a 17.96% increase compared to previous quarter)
  • Year-over-year quarterly Accounts Payable increased by 4.98%
  • Annual Accounts Payable for 2021 was $1.05 Million (a 246.03% increase from previous year)
  • Annual Accounts Payable for 2020 was $302 Thousand (a -8.76% decrease from previous year)
  • Annual Accounts Payable for 2019 was $331 Thousand (a -39.93% decrease from previous year)
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Accounts Payable of NovaBay Pharmaceuticals, Inc.

Most recent Accounts Payableof NBY including historical data for past 10 years.

Interactive Chart of Accounts Payable of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Accounts Payable for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $1.1 $0.93 $1.56
2021 $1.05 $1.35 $0.21 $0.83 $1.05
2020 $0.3 $0.8 $1.29 $0.6 $0.3
2019 $0.33 $0.5 $0.36 $0.46 $0.33
2018 $0.55 $0.56 $0.33 $0.3 $0.55
2017 $0.47 $0.36 $0.91 $0.8 $0.47
2016 $0.46 $0.39 $0.86 $1.82 $0.46
2015 $2.48 $2.87 $1.78 $2.18 $2.48
2014 $1.87 $0.92 $0.52 $0.49 $1.87
2013 $1.67 $1.01 $0.61 $0.54 $1.67
2012 $0.46 $1.05 $0.9 $0.44 $0.46
2011 $0.47 $0.47

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology